Global gene expression profiling displays a network of dysregulated genes in non-atherosclerotic arterial tissue from patients with type 2 diabetes

Cardiovascular Diabetology

Volumn 11, Issue , 2012, Pages

  Skov, Vibe ^a   Knudsen, Steen ^b   Olesen, Malene ^a   Hansen, Maria L ^a   Rasmussen, Lars M ^a  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b Medical Prognosis Institute A/S   (Denmark)

Author keywords

Coronary artery disease; Diabetes mellitus; Gene expression; Microarray; Systems biology

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 1; BREAKPOINT CLUSTER REGION PROTEIN; CASPASE 10; CASPASE 4; CASPASE 7; CD82 ANTIGEN; CELL PROTEIN; FAS ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INSULIN; MATRIX METALLOPROTEINASE 14; NON RECEPTOR PROTEIN TYROSINE PHOSPHATASE 12; PROTEIN CDC42; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADIPOGENESIS; ADULT; AGED; APOPTOSIS; ARTERY; ARTICLE; CHOLESTEROL SYNTHESIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; DNA MICROARRAY; GENE EXPRESSION; GENE EXPRESSION PROFILING; HISTOLOGY; HUMAN; HUMAN TISSUE; LIPOGENESIS; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; ONCOGENE N RAS; SIGNAL TRANSDUCTION; BIOPSY; CASE CONTROL STUDY; GENE; GENETICS; INFLAMMATION; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

AGED; APOPTOSIS; ARTERIES; BIOPSY; CASE-CONTROL STUDIES; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION PROFILING; GENES; HUMANS; INFLAMMATION; INSULIN; MALE; MIDDLE AGED; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; TRIGLYCERIDES;

EID: 84857020740     PISSN: None     EISSN: 14752840     Source Type: Journal    
DOI: 10.1186/1475-2840-11-15     Document Type: Article

References (45)

1. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979, 2:120-126. 10.2337/diacare.2.2.120, 520114.
2. Goldberg IJ. Why does diabetes increase atherosclerosis? I don't know!. J Clin Invest 2004, 114:613-615. 514600, 15343377.
3. De Vriese AS, Verbeuren TJ, van d V, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 2000, 130:963-974. 10.1038/sj.bjp.0703393, 1572156, 10882379.
4. Feldt-Rasmussen B. Microalbuminuria, endothelial dysfunction and cardiovascular risk. Diabetes Metab 2000, 26(Suppl 4):64-66.
5. Ribau JC, Hadcock SJ, Teoh K, DeReske M, Richardson M. Endothelial adhesion molecule expression is enhanced in the aorta and internal mammary artery of diabetic patients. J Surg Res 1999, 85:225-233. 10.1006/jsre.1999.5682, 10423323.
6. Rask-Madsen C, Ihlemann N, Krarup T, Christiansen E, Kober L, Nervil KC, Torp-Pedersen C. Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 2001, 50:2611-2618. 10.2337/diabetes.50.11.2611, 11679442.
7. Rasmussen LM, Ledet T. Aortic collagen alterations in human diabetes mellitus. Changes in basement membrane collagen content and in the susceptibility of total collagen to cyanogen bromide solubilisation. Diabetologia 1993, 36:445-453. 10.1007/BF00402282, 8314450.
8. Heickendorff L, Ledet T, Rasmussen LM. Glycosaminoglycans in the human aorta in diabetes mellitus: a study of tunica media from areas with and without atherosclerotic plaque. Diabetologia 1994, 37:286-292. 10.1007/BF00398056, 8174843.
9. Olesen P, Ledet T, Rasmussen LM. Arterial osteoprotegerin: increased amounts in diabetes and modifiable synthesis from vascular smooth muscle cells by insulin and TNF-alpha. Diabetologia 2005, 48:561-568. 10.1007/s00125-004-1652-8, 15700136.
10. Chung AW, Booth AD, Rose C, Thompson CR, Levin A, van BC. Increased matrix metalloproteinase 2 activity in the human internal mammary artery is associated with ageing, hypertension, diabetes and kidney dysfunction. J Vasc Res 2008, 45:357-362. 10.1159/000119755, 18332634.
11. Sims TJ, Rasmussen LM, Oxlund H, Bailey AJ. The role of glycation cross-links in diabetic vascular stiffening. Diabetologia 1996, 39:946-951. 10.1007/BF00403914, 8858217.
12. Ruiz E, Gordillo-Moscoso A, Padilla E, Redondo S, Rodriguez E, Reguillo F, Briones AM, van BC, Okon E, Tejerina T. Human vascular smooth muscle cells from diabetic patients are resistant to induced apoptosis due to high Bcl-2 expression. Diabetes 2006, 55:1243-1251. 10.2337/db05-0949, 16644678.
13. Neubauer B. A quantitative study of peripheral arterial calcification and glucose tolerance in elderly diabetics and non-diabetics. Diabetologia 1971, 7:409-413. 10.1007/BF01212055, 5144548.
14. Lehto S, Niskanen L, Suhonen M, Ronnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996, 16:978-983. 10.1161/01.ATV.16.8.978, 8696962.
15. Sista AK, O'Connell MK, Hinohara T, Oommen SS, Fenster BE, Glassford AJ, Schwartz EA, Taylor CA, Reaven GM, Tsao PS. Increased aortic stiffness in the insulin-resistant Zucker fa/fa rat. Am J Physiol Heart Circ Physiol 2005, 289:H845-H851. 10.1152/ajpheart.00134.2005, 15833807.
16. Heinonen SE, Leppanen P, Kholova I, Lumivuori H, Hakkinen SK, Bosch F, Laakso M, Yla-Herttuala S. Increased atherosclerotic lesion calcification in a novel mouse model combining insulin resistance, hyperglycemia, and hypercholesterolemia. Circ Res 2007, 101:1058-1067. 10.1161/CIRCRESAHA.107.154401, 17872464.
17. Renard CB, Kramer F, Johansson F, Lamharzi N, Tannock LR, von Herrath MG, Chait A, Bornfeldt KE. Diabetes and diabetes-associated lipid abnormalities have distinct effects on initiation and progression of atherosclerotic lesions. J Clin Invest 2004, 114:659-668. 514580, 15343384.
18. Cangemi C, Skov V, Poulsen MK, Funder J, Twal WO, Gall MA, Hjortdal V, Jespersen ML, Kruse TA, Aagard J, Parving HH, Knudsen S, Hoilund-Carlsen PF, Rossing P, Henriksen JE, Argraves WS, Rasmussen LM. Fibulin-1 is a Marker for Arterial Extracellular Matrix Alterations in Type 2 Diabetes. Clin Chem 2011, 57:1556-1565. 10.1373/clinchem.2011.162966, 21926180.
19. Fassot C, Briet M, Rostagno P, Barbry P, Perret C, Laude D, Boutouyrie P, Bozec E, Bruneval P, Latremouille C, Laurent S. Accelerated arterial stiffening and gene expression profile of the aorta in patients with coronary artery disease. J Hypertens 2008, 26:747-757. 10.1097/HJH.0b013e3282f4b3d0, 18327085.
20. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, Paulovich A, Pomeroy SL, Golub TR, Lander ES, Mesirov JP. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 2005, 102:15545-15550. 10.1073/pnas.0506580102, 1239896, 16199517.
21. Doniger SW, Salomonis N, Dahlquist KD, Vranizan K, Lawlor SC, Conklin BR. MAPPFinder: using Gene Ontology and GenMAPP to create a global gene-expression profile from microarray data. Genome Biol 2003, 4:R7. 10.1186/gb-2003-4-1-r7, 151291, 12540299.
22. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 2003, 13:2498-2504. 10.1101/gr.1239303, 403769, 14597658.
23. Barabasi AL, Oltvai ZN. Network biology: understanding the cell's functional organization. Nat Rev Genet 2004, 5:101-113. 10.1038/nrg1272, 14735121.
24. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B 1995, 57:289-300.
25. McLachlan JL, Smith AJ, Bujalska IJ, Cooper PR. Gene expression profiling of pulpal tissue reveals the molecular complexity of dental caries. Biochim Biophys Acta 2005, 1741:271-281.
26. Flechner SM, Kurian SM, Head SR, Sharp SM, Whisenant TC, Zhang J, Chismar JD, Horvath S, Mondala T, Gilmartin T, Cook DJ, Kay SA, Walker JR, Salomon DR. Kidney transplant rejection and tissue injury by gene profiling of biopsies and peripheral blood lymphocytes. Am J Transplant 2004, 4:1475-1489. 10.1111/j.1600-6143.2004.00526.x, 2041877, 15307835.
27. Rome S, Clement K, Rabasa-Lhoret R, Loizon E, Poitou C, Barsh GS, Riou JP, Laville M, Vidal H. Microarray profiling of human skeletal muscle reveals that insulin regulates approximately 800 genes during a hyperinsulinemic clamp. J Biol Chem 2003, 278:18063-18068. 10.1074/jbc.M300293200, 12621037.
28. Govoni KE, Lee SK, Chadwick RB, Yu H, Kasukawa Y, Baylink DJ, Mohan S. Whole genome microarray analysis of growth hormone-induced gene expression in bone: T-box3, a novel transcription factor, regulates osteoblast proliferation. Am J Physiol Endocrinol Metab 2006, 291:E128-E136. 10.1152/ajpendo.00592.2005, 3000614, 16464905.
29. Lazenby MG, Crook MA. The innate immune system and diabetes mellitus: the relevance of periodontitis? A hypothesis. Clin Sci (Lond) 2010, 119:423-429.
30. Campus G, Salem A, Uzzau S, Baldoni E, Tonolo G. Diabetes and periodontal disease: a case-control study. J Periodontol 2005, 76:418-425. 10.1902/jop.2005.76.3.418, 15857077.
31. Li J, Jin C, Cleveland JC, Ao L, Xu D, Fullerton DA, Meng X. Enhanced inflammatory responses to toll-like receptor 2/4 stimulation in type 1 diabetic coronary artery endothelial cells: the effect of insulin. Cardiovasc Diabetol 2010, 9:90. 10.1186/1475-2840-9-90, 3018430, 21162749.
32. Erridge C, Samani NJ. Saturated fatty acids do not directly stimulate Toll-like receptor signaling. Arterioscler Thromb Vasc Biol 2009, 29:1944-1949. 10.1161/ATVBAHA.109.194050, 19661481.
33. Erikstrup C, Pedersen LM, Heickendorff L, Ledet T, Rasmussen LM. Production of hyaluronan and chondroitin sulphate proteoglycans from human arterial smooth muscle--the effect of glucose, insulin, IGF-I or growth hormone. Eur J Endocrinol 2001, 145:193-198. 10.1530/eje.0.1450193, 11454516.
34. Stout RW. Development of vascular lesions in insulin-treated animals fed a normal diet. Br Med J 1970, 3:685-687. 10.1136/bmj.3.5724.685, 1701806, 5470117.
35. Stout RW. Insulin and atherosclerosis. Lancet 1969, 2:327-328.
36. Bansilal S, Farkouh ME, Fuster V. Role of insulin resistance and hyperglycemia in the development of atherosclerosis. Am J Cardiol 2007, 99:6B-14B.
37. Rask-Madsen C, Ihlemann N, Krarup T, Christiansen E, Kober L, Nervil KC, Torp-Pedersen C. Insulin therapy improves insulin-stimulated endothelial function in patients with type 2 diabetes and ischemic heart disease. Diabetes 2001, 50:2611-2618. 10.2337/diabetes.50.11.2611, 11679442.
38. Jiang ZY, Lin YW, Clemont A, Feener EP, Hein KD, Igarashi M, Yamauchi T, White MF, King GL. Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999, 104:447-457. 10.1172/JCI5971, 408521, 10449437.
39. Rask-Madsen C, Li Q, Freund B, Feather D, Abramov R, Wu IH, Chen K, Yamamoto-Hiraoka J, Goldenbogen J, Sotiropoulos KB, Clermont A, Geraldes P, Dall'Osso C, Wagers AJ, Huang PL, Rekhter M, Scalia R, Kahn CR, King GL. Loss of insulin signaling in vascular endothelial cells accelerates atherosclerosis in apolipoprotein E null mice. Cell Metab 2010, 11:379-389. 10.1016/j.cmet.2010.03.013, 3020149, 20444418.
40. Reusch JE, Draznin BB. Atherosclerosis in diabetes and insulin resistance. Diabetes Obes Metab 2007, 9:455-463. 10.1111/j.1463-1326.2006.00620.x, 17587387.
41. Baelde HJ, Eikmans M, Doran PP, Lappin DW, de HE, Bruijn JA. Gene expression profiling in glomeruli from human kidneys with diabetic nephropathy. Am J Kidney Dis 2004, 43:636-650. 10.1053/j.ajkd.2003.12.028, 15042541.
42. Wogensen L, Nielsen CB, Hjorth P, Rasmussen LM, Nielsen AH, Gross K, Sarvetnick N, Ledet T. Under control of the Ren-1c promoter, locally produced transforming growth factor-beta1 induces accumulation of glomerular extracellular matrix in transgenic mice. Diabetes 1999, 48:182-192. 10.2337/diabetes.48.1.182, 9892241.
43. Ziyadeh FN. Mediators of diabetic renal disease: the case for tgf-Beta as the major mediator. J Am Soc Nephrol 2004, 15(Suppl 1):S55-S57.
44. Woroniecka KI, Park AS, Mohtat D, Thomas DB, Pullman JM, Susztak K. Transcriptome analysis of human diabetic kidney disease. Diabetes 2011, 60:2354-2369. 10.2337/db10-1181, 21752957.
45. Chung AW, Yang HH, Sigrist MK, Brin G, Chum E, Gourlay WA, Levin A. Matrix metalloproteinase-2 and -9 exacerbate arterial stiffening and angiogenesis in diabetes and chronic kidney disease. Cardiovasc Res 2009, 84:494-504. 10.1093/cvr/cvp242, 19617223.